News - IMSDA

CDSCO 2026 Overhaul: GMP Audits Outsourced, 1,500 Experts Hired as India Tightens Pharma Quality Standards

Post published:June 3, 2026
Post category:News

The Central Drugs Standard Control Organization (CDSCO) is undertaking its most significant regulatory transformation in decades. In a series of reforms announced in early 2026, India's drug regulator has unveiled…

CDSCO 2026 Reforms: Prior Intimation, GMP Audits & Faster Drug Approvals

Post published:June 1, 2026
Post category:News

The Central Drugs Standard Control Organization (CDSCO), India's national drug regulatory authority, has undertaken the most significant regulatory modernization in its history during the first half of 2026. From introducing…

US 100% Pharma Tariff Spares Indian Generics — What Buyers and Exporters Need to Know

Post published:May 28, 2026
Post category:News

The United States imposed a sweeping 100% tariff on patented pharmaceutical imports on April 2, 2026, under Section 232 of the Trade Expansion Act. However, generic medicines — which make…

CDSCO Launches Major Overhaul: Outsourcing GMP Audits and Building 1500-Expert Scientific Cadre

Post published:May 26, 2026
Post category:News

India's Central Drugs Standard Control Organisation (CDSCO) is embarking on the most significant regulatory restructuring in its history. In a move designed to strengthen pharmaceutical quality oversight and align with…